Ensuring reproducible analysis results in SARS-CoV-2 research

Since the emergence of the COVID-19 pandemic, extensive studies have continued to explore the disease pathogenesis, as well as acquired and induced immunity against the infection. With the recent development and dissemination of COVID-19 vaccinations, cellular analysis of  T and B cells has become crucial not only for patient monitoring, but also in evaluating the efficiency of immunization of candidate and established vaccines. 

Working with these rare cells can prove challenging to researchers: critically low cell frequencies, inflammatory environments, unspecific labeling, and high levels of background noise often hamper reliable analysis. In this webinar, we will introduce solutions for the efficient and reproducible analysis of these cell types in 
SARS-CoV-2 research.  

Learning objectives:

• Importance of cellular analysis in SARS-CoV-2 research 
• Precise analysis of SARS-CoV-2–reactive T cells in PBMC or whole blood samples 
• Detection, phenotyping, and sorting of SARS-CoV-2–specific B cells